CROSS COUNTRY HEALTHCARE INC (CCRN)
Data as of , from SEC Form 4 filings.
See up to 3 months of CCRN. The 7-day demo opens the 1M and 3M ranges and puts CCRN on your watchlist.
Start 7-day demoLatest CCRN insider trades
About CROSS COUNTRY HEALTHCARE INC (CCRN)
The SEC lists CROSS COUNTRY HEALTHCARE INC under CIK 0001141103, in help supply services. We track it alongside the rest of the Industrials sector.
CCRN Form 4 activity by transaction type, last 90 days
No Form 4 activity for CCRN in the last 90 days.
CCRN insider transactions (Form 4)
5748 Form 4 filings on record, the earliest from Dec 31, 2024, newest first. Filing history page 1 of 2.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Marvin Veizaga - Officer | Derivative | Common Stock | 31,480 | $13.25 | $417K | |
| Marvin Veizaga - Officer | Grant or award | Common Stock | 16,797 | $0.00 | - | |
| Marvin Veizaga - Officer | Derivative | Common Stock | 16,797 | $13.25 | $223K | |
| Amiee Lin Hawkins - Officer | Derivative | Common Stock | 27,897 | $13.25 | $370K | |
| Amiee Lin Hawkins - Officer | Derivative | Common Stock | 43,953 | $13.25 | $582K | |
| Amiee Lin Hawkins - Officer | Grant or award | Common Stock | 27,897 | $0.00 | - | |
| Marc S. Krug - Officer | Derivative | Common Stock | 77,232 | $13.25 | $1.02M | |
| Marc S. Krug - Officer | Grant or award | Common Stock | 47,120 | $0.00 | - | |
| Marc S. Krug - Officer | Derivative | Common Stock | 47,120 | $13.25 | $624K | |
| Susan E. Ball - Officer | Derivative | Common Stock | 241,777 | $13.25 | $3.20M | |
| Susan E. Ball - Officer | Grant or award | Common Stock | 72,872 | $0.00 | - | |
| Susan E. Ball - Officer | Derivative | Common Stock | 72,872 | $13.25 | $966K | |
| William J. Burns - Officer | Derivative | Common Stock | 336,438 | $13.25 | $4.46M | |
| William J. Burns - Officer | Grant or award | Common Stock | 104,157 | $0.00 | - | |
| William J. Burns - Officer | Derivative | Common Stock | 104,157 | $13.25 | $1.38M | |
| Kevin Cronin Clark - Officer | Derivative | Common Stock | 948,133 | $13.25 | $12.56M | |
| Kevin Cronin Clark - Officer | Grant or award | Common Stock | 247,416 | $0.00 | - | |
| Kevin Cronin Clark - Officer | Derivative | Common Stock | 247,416 | $13.25 | $3.28M | |
| Kevin Cronin Clark - Officer | Derivative | Common Stock | 3,961 | $13.25 | $52K | |
| Janice Elizabeth Nevin - Director | Derivative | Common Stock | 48,616 | $13.25 | $644K | |
| Gale S. Fitzgerald - Director | Derivative | Common Stock | 114,331 | $13.25 | $1.51M | |
| Gale S. Fitzgerald - Director | Derivative | Common Stock | 79,918 | $13.25 | $1.06M | |
| W. Larry Cash - Director | Derivative | Common Stock | 223,312 | $13.25 | $2.96M | |
| Venkat Bhamidipati - Director | Derivative | Common Stock | 29,759 | $13.25 | $394K | |
| Dwayne Allen - Director | Derivative | Common Stock | 31,289 | $13.25 | $415K | |
| Marvin Veizaga - Officer | Tax withholding / forfeiture | Common Stock | 236 footnote F1 | $13.21 | $3K | |
| ||||||
| Marc S. Krug - Officer | Grant or award | Common Stock | 21,024 footnote F1 | $0.00 | - | |
| Marc S. Krug - Officer | Tax withholding / forfeiture | Common Stock | 1,123 footnote F2 | $9.40 | $11K | |
| Marc S. Krug - Officer | Tax withholding / forfeiture | Common Stock | 1,339 footnote F2 | $9.40 | $13K | |
| ||||||
| Amiee Lin Hawkins - Officer | Grant or award | Common Stock | 15,958 footnote F1 | $0.00 | - | |
| Amiee Lin Hawkins - Officer | Tax withholding / forfeiture | Common Stock | 583 footnote F2 | $9.40 | $5K | |
| Amiee Lin Hawkins - Officer | Tax withholding / forfeiture | Common Stock | 695 footnote F2 | $9.40 | $7K | |
| ||||||
| Kevin Cronin Clark - Officer | Grant or award | Common Stock | 138,963 footnote F1 | $0.00 | - | |
| ||||||
| William J. Burns - Officer | Tax withholding / forfeiture | Common Stock | 2,890 footnote F2 | $9.40 | $27K | |
| William J. Burns - Officer | Grant or award | Common Stock | 47,873 footnote F1 | $0.00 | - | |
| William J. Burns - Officer | Tax withholding / forfeiture | Common Stock | 2,423 footnote F2 | $9.40 | $23K | |
| ||||||
| Susan E. Ball - Officer | Grant or award | Common Stock | 33,644 footnote F1 | $0.00 | - | |
| Susan E. Ball - Officer | Tax withholding / forfeiture | Common Stock | 1,689 footnote F2 | $9.40 | $16K | |
| Susan E. Ball - Officer | Tax withholding / forfeiture | Common Stock | 2,014 footnote F2 | $9.40 | $19K | |
| ||||||
| Marvin Veizaga - Officer | Grant or award | Common Stock | 9,043 footnote F1 | $0.00 | - | |
| Marvin Veizaga - Officer | Tax withholding / forfeiture | Common Stock | 501 footnote F3 | $9.40 | $5K | |
| Marvin Veizaga - Officer | Tax withholding / forfeiture | Common Stock | 437 footnote F3 | $9.40 | $4K | |
| ||||||
| Colin Patrick McDonald - Officer | Open-market sale | Common Stock | 6,200 | $9.70 footnote F1 | $60K | |
| ||||||
| Susan E. Ball - Officer | Tax withholding / forfeiture | Common Stock | 1,740 | $14.89 | $26K | |
| Susan E. Ball - Officer | Tax withholding / forfeiture | Common Stock | 1,689 | $14.89 | $25K | |
| Susan E. Ball - Officer | Tax withholding / forfeiture | Common Stock | 2,015 | $14.89 | $30K | |
| Susan E. Ball - Officer | Tax withholding / forfeiture | Common Stock | 3,942 | $14.89 | $59K | |
| Janice Elizabeth Nevin - Director | Grant or award | Common Stock | 18,680 footnote F1 | $0.00 | - | |
| ||||||
| Gale S. Fitzgerald - Director | Grant or award | Common Stock | 18,680 footnote F1 | $0.00 | - | |
| ||||||
| W. Larry Cash - Director | Grant or award | Common Stock | 18,680 footnote F1 | $0.00 | - | |
| ||||||
| Venkat Bhamidipati - Director | Grant or award | Common Stock | 18,680 footnote F1 | $0.00 | - | |
| ||||||
| Dwayne Allen - Director | Grant or award | Common Stock | 18,680 footnote F1 | $0.00 | - | |
| ||||||
| James V. Redd III - Officer | Grant or award | Common Stock | 12,311 footnote F1 | $0.00 | - | |
| ||||||
| Phillip Lyn Noe - Officer | Grant or award | Common Stock | 12,826 footnote F1 | $0.00 | - | |
| ||||||
| Karen Mote - Officer | Grant or award | Common Stock | 8,095 footnote F1 | $0.00 | - | |
| ||||||
| Colin Patrick McDonald - Officer | Grant or award | Common Stock | 9,340 footnote F1 | $0.00 | - | |
| ||||||
| Marc S. Krug - Officer | Grant or award | Common Stock | 23,817 footnote F1 | $0.00 | - | |
| ||||||
CCRN insider trading FAQ
What is the latest insider trade for CCRN?
CROSS COUNTRY HEALTHCARE INC (CCRN) has filed no insider reports in the last 90 days. The most recent on record is dated 21 July 2026. The full record for CCRN runs to 48 Form 4 filings, the earliest from 31 December 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CCRN stock?
No insider purchases of CCRN were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling CCRN stock?
No insider sales of CCRN were filed in the last 90 days. 1 sale is on record for this company.
Where can I see CCRN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CCRN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Industrials companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Marvin Veizaga view on EDGAR
- - Amiee Lin Hawkins view on EDGAR
- - Marc S. Krug view on EDGAR
- - Susan E. Ball view on EDGAR
- - William J. Burns view on EDGAR
- - Kevin Cronin Clark view on EDGAR
- - Janice Elizabeth Nevin view on EDGAR
- - Gale S. Fitzgerald view on EDGAR
- - W. Larry Cash view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Industrials
- Where CCRN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CCRN with a 7-day demo
- CCRN on your watchlist
- Every CCRN Form 4 filing on record
- Up to 3 months of CCRN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive